Floatz logo

Fezolinetant

Hot Flashes

Shehzad Basaria, M.D.Small moleculePhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Hot Flashes cohort.

Asset / SponsorPhaseRating
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Mayo Clinic
Phase 3BB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Northwestern University
Phase 4BB
Seroquel®
McMaster University
Phase 4BB
TAMOXIFEN
Astellas Pharma Global Development, Inc.
Phase 3BB
DESVENLAFAXINE
Seoul National University Hospital
Phase 4BB

View all 31 →

Same molecule, other indications

Fezolinetant is also rated in:

prostate adenocarcinomaDormant
CCC
Indicative ·
53 / 100
View asset →
Vasomotor SymptomsDormant
CCC
Indicative ·
53 / 100
View asset →
prostate cancerDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →